Maria Pisu1, Joshua Richman, Jeroan J Allison, O Dale Williams, Catarina I Kiefe. 1. Center for Outcomes and Effectiveness Research and Education and Division of Preventive Medicine, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract
OBJECTIVES: This study examined how physicians perceive pharmaceutical companies' medication assistance programs (MAPs). METHODS: The study was conducted using a survey of 373 primary care physicians from four southern states; they were surveyed within the formative evaluation phase of a larger study (MI-Plus). Respondents were queried about use and usefulness of MAPs for patients who cannot afford drugs, and barriers to using them. Bivariate associations between physician-level variables (patients without drug coverage) and usefulness and barriers to using MAPs were assessed using Chi square tests. Independence of associations was assessed using multiple logistic regressions. RESULTS: Of the 364 (97.6%) respondents who used MAPs, 70% used them regularly, the rest occasionally; 63% found MAPs very useful in caring for patients who could not afford drugs. About 89% reported one or more barriers to using MAPs; 47% saw "inability of patients to apply directly;" and 57% saw "enrollment process being time-consuming for staff" as barriers. Compared to physicians with fewer elderly patients without drug coverage, those with more of these patients were less likely to find MAPs very useful; less likely to report no barriers to using MAPs; and more likely to see "low income thresholds" and "inability of patients to apply directly" as barriers. CONCLUSION: While MAPs are considered useful in caring for patients in need of assistance, there are many barriers to their use. Pharmaceutical companies should address these barriers. Limitations include a low response rate (about 10%).
OBJECTIVES: This study examined how physicians perceive pharmaceutical companies' medication assistance programs (MAPs). METHODS: The study was conducted using a survey of 373 primary care physicians from four southern states; they were surveyed within the formative evaluation phase of a larger study (MI-Plus). Respondents were queried about use and usefulness of MAPs for patients who cannot afford drugs, and barriers to using them. Bivariate associations between physician-level variables (patients without drug coverage) and usefulness and barriers to using MAPs were assessed using Chi square tests. Independence of associations was assessed using multiple logistic regressions. RESULTS: Of the 364 (97.6%) respondents who used MAPs, 70% used them regularly, the rest occasionally; 63% found MAPs very useful in caring for patients who could not afford drugs. About 89% reported one or more barriers to using MAPs; 47% saw "inability of patients to apply directly;" and 57% saw "enrollment process being time-consuming for staff" as barriers. Compared to physicians with fewer elderly patients without drug coverage, those with more of these patients were less likely to find MAPs very useful; less likely to report no barriers to using MAPs; and more likely to see "low income thresholds" and "inability of patients to apply directly" as barriers. CONCLUSION: While MAPs are considered useful in caring for patients in need of assistance, there are many barriers to their use. Pharmaceutical companies should address these barriers. Limitations include a low response rate (about 10%).
Authors: Jeanne M Madden; Amy J Graves; Fang Zhang; Alyce S Adams; Becky A Briesacher; Dennis Ross-Degnan; Jerry H Gurwitz; Marsha Pierre-Jacques; Dana Gelb Safran; Gerald S Adler; Stephen B Soumerai Journal: JAMA Date: 2008-04-23 Impact factor: 56.272
Authors: Duane M Kirking; James A Lee; Jeffrey J Ellis; Becky Briesacher; Patrick L McKercher Journal: Med Care Res Rev Date: 2006-08 Impact factor: 3.929
Authors: Gary N Harmon; John Lefante; Wendy Roy; Keith H Ashby; Danny Jackson; David Barnard; Allen Smart; Larry Webber Journal: Am J Health Syst Pharm Date: 2004-03-15 Impact factor: 2.637
Authors: Michelle Y Martin; Young-il Kim; Polly Kratt; Mark S Litaker; Connie L Kohler; Yu-Mei Schoenberger; Stephen J Clarke; Heather Prayor-Patterson; Tung-Sung Tseng; Maria Pisu; O Dale Williams Journal: Am J Health Promot Date: 2011 Jul-Aug
Authors: Angie Leon-Salas; Jamie J Hunt; Kimber P Richter; Niaman Nazir; Edward F Ellerbeck; Theresa I Shireman Journal: J Am Pharm Assoc (2003) Date: 2016-11-03